Evaluating the clinical outcomes associated with a modified prolonged infusion piperacillin–tazobactam protocol: A pilot study
Year: 2015
Type: article
Study design: Observational Study
Abstract: Purpose: This study evaluated the clinical outcomes of a hospital-wide initiative of a 4-h prolonged infusion piperacillin–tazobactam (pip–tz) vs. a 30-min and a 4-h prolonged infusion. Methods: This retrospective study included patients who received pip–tz by two different infusion models with a documented or suspected Gram-negative infection. Patients can receive a 30-min infusion then a 4-h infusion or a 4-h infusion of pip–tz. The study’s primary outcomes were length of stay (LOS) and 30-day mortality. Findings: Seventy-four patients received both types of infusion (SP) and 275 patients received only the prolonged infusion (PI). Using univariate analysis, the PI group had a higher mortality rate (13%) vs. SP group (4%) (p = 0.033). The PI group had a higher mean LOS (12.6 ± 9.5 days) vs. the SP group (10.3 ± 8.2 days) (p = 0.04). The type of infusion was not a significant predictor of LOS or mortality in multiple regression analysis (p > 0.05). Implications: This preliminary study showed that the PI group had a higher mortality rate and LOS compared to the SP group. However, this finding was not replicated using multiple regression analysis probably due to small sample sizes. Further studies using larger samples are warranted to clarify the clinical effectiveness of the different practices of prolonged infusion piperacillin–tazobactam.
Source: Cogent Medicine
Authors: Lee H. Nguyen, Paul Gavaza
Institutions: Loma Linda University, St. Jude Medical Center
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,165
Funders: Loma Linda University, St. Jude Medical
OpenAlex ID: W1488499230
